Applied Therapeutics Receives Complete Response Letter From U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
Sector Update: Health Care
US Equity Futures Tread Water Ahead of Shortened Black Friday Session
RBC Downgrades Applied Therapeutics as FDA Rejects Govorestat, Hacks Price Target
Express News | Applied Therapeutics Shares Are Trading Lower After the Company Announced the FDA Highlighted Deficiencies in a Clinical Application for a Lead Program
RBC Capital Initiates Applied Therapeutics(APLT.US) With Hold Rating, Announces Target Price $12
